ProfileGDS4718 / 206947_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 70% 31% 73% 70% 41% 28% 76% 79% 76% 68% 74% 68% 34% 51% 69% 72% 52% 63% 38% 77% 74% 74% 71% 69% 56% 68% 24% 73% 49% 64% 38% 79% 83% 43% 35% 56% 71% 78% 30% 69% 30% 49% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6627267
GSM549102patient 115, normal, homogenized [OPG study]6.824370
GSM549104patient 119, normal, homogenized [OPG study]4.5524531
GSM549108patient 138, normal, homogenized [OPG study]7.1021173
GSM549119patient 077, normal, homogenized [OPG study]6.8186970
GSM549133patient 032, cancer, homogenized [OPG study]4.961141
GSM549139patient 042, cancer, homogenized [OPG study]4.4228828
GSM549099patient 107, normal, homogenized [OPG study]7.3695776
GSM549109patient 139, normal, homogenized [OPG study]7.7356679
GSM549110patient 046, normal, homogenized [OPG study]7.424176
GSM549114patient 063, normal, homogenized [OPG study]6.6998468
GSM549122patient 082, normal, homogenized [OPG study]7.2669974
GSM549134patient 033, cancer, homogenized [OPG study]6.7226168
GSM549136patient 036, cancer, homogenized [OPG study]4.6720334
GSM549140patient 044, cancer, homogenized [OPG study]5.5415451
GSM549111patient 047, normal, homogenized [OPG study]6.8465869
GSM549113patient 057, normal, homogenized [OPG study]7.0991672
GSM549132patient 031, cancer, homogenized [OPG study]5.6262552
GSM549137patient 038, cancer, homogenized [OPG study]6.3390763
GSM549142patient 047, cancer, homogenized [OPG study]5.0066238
GSM549100patient 110, normal, homogenized [OPG study]7.4179977
GSM549107patient 135, normal, homogenized [OPG study]7.2696574
GSM549115patient 068, normal, homogenized [OPG study]7.2977574
GSM549116patient 072, normal, homogenized [OPG study]6.9631871
GSM549120patient 078, normal, homogenized [OPG study]6.7988569
GSM549131patient 030, cancer, homogenized [OPG study]5.8168156
GSM549118patient 074, normal, homogenized [OPG study]6.6913568
GSM549129patient 027, cancer, homogenized [OPG study]4.2967724
GSM549123patient 088, normal, homogenized [OPG study]7.1618673
GSM549124patient 006, cancer, homogenized [OPG study]5.4576449
GSM549126patient 015, cancer, homogenized [OPG study]6.3789964
GSM549128patient 025, cancer, homogenized [OPG study]4.8764438
GSM549103patient 117, normal, homogenized [OPG study]7.626379
GSM549117patient 073, normal, homogenized [OPG study]8.2378683
GSM549138patient 041, cancer, homogenized [OPG study]5.0989243
GSM549141patient 045, cancer, homogenized [OPG study]4.6906135
GSM549130patient 028, cancer, homogenized [OPG study]5.8838156
GSM549101patient 111, normal, homogenized [OPG study]6.953271
GSM549105patient 128, normal, homogenized [OPG study]7.5997578
GSM549106patient 134, normal, homogenized [OPG study]4.4740230
GSM549112patient 048, normal, homogenized [OPG study]6.7418869
GSM549125patient 011, cancer, homogenized [OPG study]4.5567930
GSM549127patient 024, cancer, homogenized [OPG study]5.4436249
GSM549135patient 035, cancer, homogenized [OPG study]4.8842539